AMOS Group Limited (SGX:49B)
0.0680
0.00 (0.00%)
Dec 9, 2024, 10:08 AM SGT
Intra-Cellular Therapies Revenue
In the fiscal year ending March 31, 2025, AMOS Group had annual revenue of 58.11M SGD, down -21.97%. AMOS Group had revenue of 28.29M in the half year ending March 31, 2025, a decrease of -44.37%.
Revenue
58.11M
Revenue Growth
-21.97%
P/S Ratio
0.24
Revenue / Employee
440.20K
Employees
132
Market Cap
14.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 58.11M | -16.36M | -21.97% |
Mar 31, 2024 | 74.47M | -24.91M | -25.07% |
Mar 31, 2023 | 99.38M | 30.70K | 0.03% |
Mar 31, 2022 | 99.35M | -9.17M | -8.45% |
Mar 31, 2021 | 108.52M | -20.10M | -15.63% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Singapore Technologies Engineering | 11.28B |
Singapore Airlines | 19.54B |
Keppel | 6.60B |
Sembcorp Industries | 6.42B |
Yangzijiang Shipbuilding (Holdings) | 4.96B |
Seatrium | 9.23B |
SATS Ltd. | 5.82B |
ComfortDelGro Corporation | 4.48B |